Standout Papers

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of ... 1997 2026 2006 2016 479
  1. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. (1997)
    Miljenko V. Pilepich, Richard Caplan et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 63 standout
Sub-graph 1 of 20

Citing Papers

Nanomedicine‐Enabled Sonomechanical, Sonopiezoelectric, Sonodynamic, and Sonothermal Therapy
2023 Standout
Prostate cancer
2021 Standout
2 intermediate papers

Works of M. Gallagher being referenced

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.
1997 Standout
1007 The need for central pathology tumor grading in prostate cancer using radiation therapy oncology group(RTOG) 8531
1997
and 1 more

Author Peers

Author Last Decade Papers Cites
M. Gallagher 723 222 115 8 768
Alphonsus C. M. van den Bergh 610 153 84 4 656
Valery Uhl 793 418 136 11 951
A.V. D’Amico 808 121 157 16 919
Reinhard Golz 703 218 219 18 833
Daphna Y. Spiegel 591 334 364 24 963
Frank A. Critz 826 362 114 25 880
Malcolm Mason 427 78 238 13 654
Andrea Moore 823 592 90 11 921
A Heidenreich 678 48 236 13 851
J.-E. Johansson 740 34 201 8 860

All Works

Loading papers...

Rankless by CCL
2026